2
|
Calugareanu A, Grolleau C, Le Buanec H, Chasset F, Jachiet M, Battistella M, Bagot M, Jullien D, Poutrel S, Bouaziz JD, Ben Said B. Clinical efficacy of selective JAK1 inhibition and transcriptome analysis of chronic discoid lupus erythematosus. J Eur Acad Dermatol Venereol 2021; 36:e308-e310. [PMID: 34839559 DOI: 10.1111/jdv.17839] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2021] [Revised: 10/24/2021] [Accepted: 11/17/2021] [Indexed: 12/25/2022]
Affiliation(s)
- A Calugareanu
- Severe Cutaneous Adverse Reaction (SCAR) Regional Center and Dermatology Department, CHU Lyon Centre, Hospices Civils de Lyon (HCL), Lyon, France.,INSERM U976, Hôpital Saint-Louis, Paris, France
| | - C Grolleau
- INSERM U976, Hôpital Saint-Louis, Paris, France.,Dermatology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - H Le Buanec
- INSERM U976, Hôpital Saint-Louis, Paris, France
| | - F Chasset
- Dermatology Department, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - M Jachiet
- INSERM U976, Hôpital Saint-Louis, Paris, France.,Dermatology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - M Battistella
- INSERM U976, Hôpital Saint-Louis, Paris, France.,Pathology Department, AP-HP, Hôpital Saint-Louis, Paris, France
| | - M Bagot
- INSERM U976, Hôpital Saint-Louis, Paris, France.,Dermatology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - D Jullien
- Severe Cutaneous Adverse Reaction (SCAR) Regional Center and Dermatology Department, CHU Lyon Centre, Hospices Civils de Lyon (HCL), Lyon, France
| | - S Poutrel
- Internal Medicine Department, CHU Lyon Centre, Hospices civils de Lyon (HCL), Lyon, France
| | - J-D Bouaziz
- INSERM U976, Hôpital Saint-Louis, Paris, France.,Dermatology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - B Ben Said
- Severe Cutaneous Adverse Reaction (SCAR) Regional Center and Dermatology Department, CHU Lyon Centre, Hospices Civils de Lyon (HCL), Lyon, France
| |
Collapse
|
3
|
Cassius C, Merandet M, Frumholtz L, Bergerat D, Samri A, Grolleau C, Grzelak L, Schwartz O, Yatim N, Moghadam P, Jaume L, Bagot M, Legoff J, Delaugerre C, Bouaziz JD, Le Buanec H. Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic. Br J Dermatol 2021; 185:1242-1244. [PMID: 34258762 PMCID: PMC8444844 DOI: 10.1111/bjd.20647] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2021] [Revised: 07/12/2021] [Accepted: 07/12/2021] [Indexed: 11/27/2022]
Affiliation(s)
- C Cassius
- Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France.,Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France
| | - M Merandet
- Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France
| | - L Frumholtz
- Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France
| | - D Bergerat
- Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France
| | - A Samri
- Sorbonne Université, Inserm 1135, Centre d'immunologie et des maladies infectieuses, Cimi-Paris, F-75013, Paris, France
| | - C Grolleau
- Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France.,Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France
| | - L Grzelak
- Institut Pasteur, Virus and immunity unit, F-75015, Paris, France
| | - O Schwartz
- Institut Pasteur, Virus and immunity unit, F-75015, Paris, France
| | - N Yatim
- Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France.,Institut Pasteur, Translational Immunology Lab, F-75015, Paris, France
| | - P Moghadam
- Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France
| | - L Jaume
- Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France
| | - M Bagot
- Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France.,Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France
| | - J Legoff
- Virology Department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France.,Université de Paris, Team Insight, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France
| | - C Delaugerre
- Virology Department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France
| | - J-D Bouaziz
- Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France.,Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France
| | - H Le Buanec
- Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France
| | | |
Collapse
|